埃塞俄比亚乳腺癌的决定因素:系统审查和元分析
Lencho Kajela Solbana1, Eshetu Ejeta Chaka2
1College of Health Science, Assosa University, PO Box 018, Assosa, Ethiopia.
Ecancermedicalscience
|February 28, 2024
概括
初潮的早期年龄,绝经后和家族癌症史是埃塞俄比亚妇女乳腺癌 (BC) 的关键决定因素. 相反,一直母乳养与BC的风险降低有关.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 乳腺癌 (BC) 是全球女性的主要癌症,约占总癌症负担的25%.
- 埃塞俄比亚面临着与BC的重大挑战,需要对其在人口中的特定决定因素进行研究.
研究的目的:
- 确定与埃塞俄比亚妇女乳腺癌 (BC) 相关的重大风险因素和保护因素.
- 为旨在减少埃塞俄比亚BC发病率和死亡率的公共卫生干预提供基于证据的建议.
主要方法:
- 对埃塞俄比亚进行的初级研究进行了系统审查和元分析.
- 通过多个数据库 (PubMed,Cochrane图书馆,Hinari,谷歌,谷歌学者) 搜索研究,截至2023年6月2日.
- 来自五项涉及1819名参与者的研究数据被分析,使用随机效应模型来估计聚合概率比率 (AOR) 和95%置信区间 (CI).
主要成果:
- 确定的BC的主要决定因素包括初潮的早期年龄 (<12岁) (AOR=3.36,95% CI:1.68-5.04) 和绝经后 (AOR=2.37,95% CI:1.67-3.06).
- 癌症家族史也是一个显著的风险因素 (AOR=2.39,95% CI:1.29-3.44).
- 长期母乳养被发现是一种保护因素,显著降低了BC风险 (AOR=0.28,95%CI:0.15-0.42).
结论:
- 该研究强调初潮时的年龄,更年期状态,母乳养史和家族史是埃塞俄比亚乳腺癌的关键决定因素.
- 建议包括提高社区意识,促进乳腺自我检查,并制定有针对性的计划,以减轻乳腺癌日益增长的负担.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Statistical Methods for Analyzing Epidemiological Data
365
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
365
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


